Eytan Stein
MD
Attending Physician, Leukemia Service
👥Biography 个人简介
Eytan Stein is a prominent hematologic oncologist specializing in novel targeted therapies for AML. He has led pivotal clinical trials of ziftomenib, a menin inhibitor showing remarkable activity in NPM1-mutant AML. His research bridges molecular biology and clinical development of differentiation therapies in acute leukemia.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Eytan Stein 的研究动态
Follow Eytan Stein's research updates
留下邮箱，当我们发布与 Eytan Stein（Memorial Sloan Kettering Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment